Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Genome Sequencing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Genome Sequencingmarket, defines the market attractiveness level of Cancer Genome Sequencing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Genome Sequencing industry, describes the types of Cancer Genome Sequencing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Genome Sequencing market and the development prospects and opportunities of Cancer Genome Sequencing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Genome Sequencing market in Chapter 13.
By Player:
Microchip Biotechnologies
Commonwealth Biotechnologies
LI-COR Biosciences
Johnson & Johnson
Abbott Laboratories
GE Healthcare Life Sciences
Beckman Coulter
Myriad Genetics
Hamilton Thorne Biosciences
Bayer Corporation
Pacific Biosciences
ZS Genetics
Agilent Technologies
By Type:
Second generation
Third generation
By End-User:
Treatment
Research
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Genome Sequencing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Genome Sequencing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Genome Sequencing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Genome Sequencing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Genome Sequencing Market Analysis and Outlook to 2022
-
7.1 Global Cancer Genome Sequencing Consumption (2017-2022)
-
7.2 United States Cancer Genome Sequencing Consumption (2017-2022)
-
7.3 Europe Cancer Genome Sequencing Consumption (2017-2022)
-
7.4 China Cancer Genome Sequencing Consumption (2017-2022)
-
7.5 Japan Cancer Genome Sequencing Consumption (2017-2022)
-
7.6 India Cancer Genome Sequencing Consumption (2017-2022)
-
7.7 South Korea Cancer Genome Sequencing Consumption (2017-2022)
8 Region and Country-wise Cancer Genome Sequencing Market Analysis and Outlook to 2028
-
8.1 Global Cancer Genome Sequencing Consumption Forecast (2022-2028)
-
8.2 United States Cancer Genome Sequencing Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Genome Sequencing Consumption Forecast (2022-2028)
-
8.4 China Cancer Genome Sequencing Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Genome Sequencing Consumption Forecast (2022-2028)
-
8.6 India Cancer Genome Sequencing Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Genome Sequencing Consumption Forecast (2022-2028)
9 Global Cancer Genome Sequencing Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Genome Sequencing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Second generation Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Third generation Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Genome Sequencing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Consumption and Growth Rate (2017-2022)
10 Global Cancer Genome Sequencing Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Genome Sequencing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Second generation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Third generation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Genome Sequencing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Genome Sequencing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Genome Sequencing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Genome Sequencing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Genome Sequencing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Genome Sequencing Market Competitive Analysis
-
14.1 Microchip Biotechnologies
-
14.1.1 Microchip Biotechnologies Company Details
-
14.1.2 Microchip Biotechnologies Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Microchip Biotechnologies Cancer Genome Sequencing Product and Service
-
14.2 Commonwealth Biotechnologies
-
14.2.1 Commonwealth Biotechnologies Company Details
-
14.2.2 Commonwealth Biotechnologies Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Commonwealth Biotechnologies Cancer Genome Sequencing Product and Service
-
14.3 LI-COR Biosciences
-
14.3.1 LI-COR Biosciences Company Details
-
14.3.2 LI-COR Biosciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 LI-COR Biosciences Cancer Genome Sequencing Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Cancer Genome Sequencing Product and Service
-
14.5 Abbott Laboratories
-
14.5.1 Abbott Laboratories Company Details
-
14.5.2 Abbott Laboratories Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abbott Laboratories Cancer Genome Sequencing Product and Service
-
14.6 GE Healthcare Life Sciences
-
14.6.1 GE Healthcare Life Sciences Company Details
-
14.6.2 GE Healthcare Life Sciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GE Healthcare Life Sciences Cancer Genome Sequencing Product and Service
-
14.7 Beckman Coulter
-
14.7.1 Beckman Coulter Company Details
-
14.7.2 Beckman Coulter Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Beckman Coulter Cancer Genome Sequencing Product and Service
-
14.8 Myriad Genetics
-
14.8.1 Myriad Genetics Company Details
-
14.8.2 Myriad Genetics Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Myriad Genetics Cancer Genome Sequencing Product and Service
-
14.9 Hamilton Thorne Biosciences
-
14.9.1 Hamilton Thorne Biosciences Company Details
-
14.9.2 Hamilton Thorne Biosciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Product and Service
-
14.10 Bayer Corporation
-
14.10.1 Bayer Corporation Company Details
-
14.10.2 Bayer Corporation Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer Corporation Cancer Genome Sequencing Product and Service
-
14.11 Pacific Biosciences
-
14.11.1 Pacific Biosciences Company Details
-
14.11.2 Pacific Biosciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pacific Biosciences Cancer Genome Sequencing Product and Service
-
14.12 ZS Genetics
-
14.12.1 ZS Genetics Company Details
-
14.12.2 ZS Genetics Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 ZS Genetics Cancer Genome Sequencing Product and Service
-
14.13 Agilent Technologies
-
14.13.1 Agilent Technologies Company Details
-
14.13.2 Agilent Technologies Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Agilent Technologies Cancer Genome Sequencing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Genome Sequencing
-
Figure Cancer Genome Sequencing Picture
-
Table Global Cancer Genome Sequencing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Genome Sequencing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Genome Sequencing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Genome Sequencing Consumption by Country (2017-2022)
-
Figure United States Cancer Genome Sequencing Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Genome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Genome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Genome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Genome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Genome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Genome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second generation Consumption and Growth Rate (2017-2022)
-
Figure Global Third generation Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Research Consumption and Growth Rate (2017-2022)
-
Figure Global Second generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Third generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Genome Sequencing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Genome Sequencing Export by Region (Top 5 Countries) (2017-2028)
-
Table Microchip Biotechnologies (Foundation Year, Company Profile and etc.)
-
Table Microchip Biotechnologies Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Microchip Biotechnologies Cancer Genome Sequencing Product and Service
-
Table Commonwealth Biotechnologies (Foundation Year, Company Profile and etc.)
-
Table Commonwealth Biotechnologies Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Commonwealth Biotechnologies Cancer Genome Sequencing Product and Service
-
Table LI-COR Biosciences (Foundation Year, Company Profile and etc.)
-
Table LI-COR Biosciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table LI-COR Biosciences Cancer Genome Sequencing Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cancer Genome Sequencing Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Cancer Genome Sequencing Product and Service
-
Table GE Healthcare Life Sciences (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare Life Sciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Life Sciences Cancer Genome Sequencing Product and Service
-
Table Beckman Coulter (Foundation Year, Company Profile and etc.)
-
Table Beckman Coulter Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beckman Coulter Cancer Genome Sequencing Product and Service
-
Table Myriad Genetics (Foundation Year, Company Profile and etc.)
-
Table Myriad Genetics Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myriad Genetics Cancer Genome Sequencing Product and Service
-
Table Hamilton Thorne Biosciences (Foundation Year, Company Profile and etc.)
-
Table Hamilton Thorne Biosciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hamilton Thorne Biosciences Cancer Genome Sequencing Product and Service
-
Table Bayer Corporation (Foundation Year, Company Profile and etc.)
-
Table Bayer Corporation Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Corporation Cancer Genome Sequencing Product and Service
-
Table Pacific Biosciences (Foundation Year, Company Profile and etc.)
-
Table Pacific Biosciences Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pacific Biosciences Cancer Genome Sequencing Product and Service
-
Table ZS Genetics (Foundation Year, Company Profile and etc.)
-
Table ZS Genetics Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table ZS Genetics Cancer Genome Sequencing Product and Service
-
Table Agilent Technologies (Foundation Year, Company Profile and etc.)
-
Table Agilent Technologies Cancer Genome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Cancer Genome Sequencing Product and Service
-
